Lnk/Sh2b3 Regulates Adipose Inflammation and Glucose Tolerance through Group 1 ILCs

1Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

Lnk/Sh2b3 is an adaptor protein that negatively regulates cytokine signaling in lymphohematopoiesis. A missense variant within the LNK/SH2B3 gene has been reported to be a risk variant for several autoimmune diseases, including diabetes. We found that glucose tolerance and insulin responses were impaired in Lnk−/− mice. Moreover, immune cells such as group 1 innate lymphoid cells (G1-ILCs), CD8+ T cells, and M1 macrophages accumulated in adipose tissue. When Lnk−/− mice were crossed with Il15−/− mice or depleted of G1-ILCs but not CD8+ T cells, glucose intolerance and adipose inflammation were ameliorated. Lnk−/− G1-ILCs showed activated phenotypes as well as enhanced reactivity for IL-15, and administration of a JAK inhibitor improved glucose tolerance. Accordingly, a high-fat diet greatly worsened glucose intolerance in Lnk−/− mice. Thus, Lnk/Sh2b3 controls homeostasis in adipose tissue and reduces the risk of onset of diabetes by regulating the expansion and activation of IL-15-dependent adipose G1-ILCs. It remains unknown how immune cells contribute to the progression of insulin resistance. Mori et al. identify a mechanism whereby Lnk/Sh2b3 regulates adipose tissue homeostasis and reduces the risk of diabetes by regulating the expansion and activation of adipose G1-ILCs, leading to insulin resistance.

Cite

CITATION STYLE

APA

Mori, T., Suzuki-Yamazaki, N., & Takaki, S. (2018). Lnk/Sh2b3 Regulates Adipose Inflammation and Glucose Tolerance through Group 1 ILCs. Cell Reports, 24(7), 1830–1841. https://doi.org/10.1016/j.celrep.2018.07.036

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free